secwatch.observer — SEC 8-K summary
======================================

Issuer:     GeneDx Holdings Corp. (WGS)
CIK:        0001818331
Form:       8-K
Filed at:   2023-04-17T23:59:59+00:00
Accession:  0001628280-23-011808
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 5.07, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GeneDx holders approve reverse split (1:10-1:50), new shares for $150M offering
-------------------------------------------------------------------------------

- Reverse stock split authorized at ratio 1:10 to 1:50, exact ratio set by board.
- Stock issuance of 22,336,624 shares approved for previously announced $150M offering.
- Officer exculpation amendment to charter approved (567M for vs 33M against).
- Equity incentive plan share reserve increased by 26M shares (503.9M for vs 97.2M against).
- Special meeting vote totals: 599,953,892 for reverse split; 595,937,112 for stock issuance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818331/000162828023011808/0001628280-23-011808-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818331/000162828023011808/smfr-20230414.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-011808

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer